期刊档案

Farmatsevtichnii chasopis

ISSN 2312-0967 · eISSN 2414-9926 · Ukrmedknyha Publishing House · Ukraine

Farmatsevtichnii chasopis 完全开放获取,收取 APC,金额未公布,投稿社区反馈审稿约 12 周,2025 年发文 59 篇。

影响因子—暂无公布值
中科院分区—未被分区表收录
CiteScore 分区—暂无 CiteScore 排名
审稿周期约 12 周投稿社区平均反馈
版面费收取 APC,金额未公布完全开放获取
录用比例—暂无反馈
年发文量59 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Farmatsevtichnii chasopis 由 Ukrmedknyha Publishing House 出版。按 OpenAlex 近年发文统计,该刊主要发表 Medical and Pharmaceutic Studies、Pharmaceutical Economics and Policy、Analytical Methods in Pharmaceuticals 等主题的论文,这 3 个主题约占 40.7%,主导子领域为 Pharmacology。(根据 OpenAlex 主题统计与中科院分区数据生成)

The journal publishes the original articles and reviews. Articles reflect best practices and research results in the pharmaceutical industry under sections: - Synthesis of biologically active compounds - Phytochemical researches - Pharmaceutical technology, biopharmacy, homeopathy, biotechnology - Analysis of drugs - Information and innovational technologies in pharmacy - Pharmaceutical management, marketing and logistics - Organization of pharmaceutical structures’ work - Economics of pharmaceutical structures - Pharmacological researches of biologically active substances - Pharmacokinetics and pharmacodynamics of drugs - Pharmacoeconomics - Nutritiology - Pharmaceutical legislation - Veterinary pharmacy - Pharmaceutical education - History of pharmacy - Chronics of events - Exchange of experience.

摘自期刊官网 Aims & Scope

主编 Mariia Shanaida出版商官网

编委会国家分布:未见中国大陆编委;主要国家 乌克兰 13、德国 1、意大利 1、波兰 1、罗马尼亚 1(共 17 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Medical and Pharmaceutic StudiesPharmacology, Toxicology and Pharmaceutics20.7%
  2. Pharmaceutical Economics and PolicyEconomics, Econometrics and Finance10.9%
  3. Analytical Methods in PharmaceuticalsChemistry9.2%
  4. Pharmacy and Medical PracticesPharmacology, Toxicology and Pharmaceutics8.7%
  5. Medicinal Plant ResearchAgricultural and Biological Sciences7.3%
  6. Drug Solubulity and Delivery SystemsPharmacology, Toxicology and Pharmaceutics5.6%
  7. Granular flow and fluidized bedsEngineering3.4%
  8. Advanced Drug Delivery SystemsPharmacology, Toxicology and Pharmaceutics3.3%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

收录数据库:暂无记录。

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

CAS出版商官网

其他:Google Scholar、Crossref、Index Copernicus、Ulrich's Periodicals Directory、JournalTOCs、ROAD、BASE (Bielefeld Academic Search Engine)

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

h-index
7OpenAlex ·
i10-index
2OpenAlex ·
两年平均被引
0.27OpenAlex ·
Gold OA 文章占比
0%LetPub ·

逐年发文量 OpenAlex 统计 · 累计 677 篇 · 当年数据不完整

年份发文量其中 OA被引
2026464633
2025595960
2024393964
20234747113
2022434377
2021404055

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
12 WeeksLetPub ·

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

完全开放获取OpenAlex

所有文章开放获取,通常向作者收取文章处理费(APC)。

来源文章处理费费用减免许可证观测时间
OpenAlexUAH 1,800——
出版商官网有,金额未公布——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

官网政策摘录作者资格、利益冲突、数据可用性、许可与版权、开放获取、同行评审、查重
作者资格 Authorship

Only persons, who have made substantive intellectual contributions to the conception, design, execution, or analysis of a study, should be listed as authors. Other participants, who took part in certain aspects of the work, should be acknowledged in the Acknowledgments paragraph. All persons listed in the paper as authors are responsible for content of the work. If the article is a multi-disciplin…

原文 ↗出版商官网 ·
利益冲突 Disclosure and Conflict of Interests

The editor-in-chief, the editorial staff and members of the Editorial Board should not use for personal purposes or transfer to third parties (without written permission of the author) unpublished manuscripts or individual data obtained from the manuscripts submitted for consideration. If there is sufficient reason to believe that the submitted manuscript or part of it is a plagiarism, the editor-…

原文 ↗出版商官网 ·
数据可用性 Data Access and Storage

Authors may be asked to provide the raw data of their study for editorial expertise and should dispose themselves to make the data publicly available if practicable. These data should be storaged for a reasonable time after publication.

原文 ↗出版商官网 ·
许可与版权

Creative Commons Attribution 4.0 International Public License 模型摘要

All materials are distributed under the terms of the Creative Commons Attribution 4.0 International Public License, which allows others to redistribute the work with acknowledgment of the authorship of the work and the first publication in this journal.

原文 ↗出版商官网 ·
开放获取 Open Access Policy

All articles published in the open-access journal “Фармацевтичний часопис. Pharmaceutical Review” have been reviewed and upon acceptance are immediately and permanently free for anyone for reading and downloading. The Editorial Board of the Фармацевтичний часопис. Pharmaceutical Review allows and encourages using of its published content supporting the principles of free distribution of scientific…

原文 ↗出版商官网 ·
同行评审 Peer Review Process

Editors registers the article, provided that it meets the requirements, published in the journal and posted on the website http://ojs.tdmu.edu.ua Article is subject to review. Chief Editor determines the scientific value of the work and appoints two reviewers - independent experts, with the closest to the subject of scientific specialization. Reviewers typically are leading scientists in the field…

原文 ↗出版商官网 ·
查重 Plagiarism

All scientific articles submitted to the editorial office are subjected to a plagiarism test by independent experts and special software Plagiat.pl and Unicheck. We protect the rights of authors/co-authors and investigate statements about plagiarism or misuse of the published articles. The authors are responsible for accuracy of the information provided in the articles, the correctness of names, s…

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
Ukrmedknyha Publishing House
出版国家或地区
Ukraine
出版语言
English, Ukrainian
ISSN
2312-0967
电子版 ISSN
2414-9926
官方链接

常见问题

关于 Farmatsevtichnii chasopis 的常见问题

Farmatsevtichnii chasopis 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 12 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Farmatsevtichnii chasopis 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 17 位编委中,没有中国大陆学者;人数最多的国家是 乌克兰(13 位)、德国(1 位)、意大利(1 位)。统计按编委会页面列出的机构国家计,仅供参考。

Farmatsevtichnii chasopis 被哪些数据库收录?

期刊官网自述还被 CAS 收录,该清单未与各数据库逐一核对。

Farmatsevtichnii chasopis 是开放获取期刊吗?版面费多少?

Farmatsevtichnii chasopis 为完全开放获取。收取 APC,金额未公布。

来源与更新

本页事实来自 LetPub、OpenAlex、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。